Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, l-652731, triazolam and alprazolam
- 1 August 1987
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 47 (3) , 249-257
- https://doi.org/10.1016/0049-3848(87)90138-1
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- PAF antagonists: different effects on platelets, neutrophils, guinea pig ileum and PAF-induced vasolidation in isolated rat lungProstaglandins, 1986
- PLATELET ACTIVATING FACTOR: A BIOLOGICALLY ACTIVE PHOSPHOGLYCERIDEAnnual Review of Biochemistry, 1986
- Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988European Journal of Pharmacology, 1986
- Effects of cv-3988, an antagonist of platelet-activating factor (paf), on washed rabbit plateletsThrombosis Research, 1986
- Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the plateletBiochemical Pharmacology, 1985
- Is platelet activating factor (PAF) a mediator of endotoxin shock?European Journal of Pharmacology, 1985
- Platelet-Activating Factor-Induced Aggregation of Human Platelets Specifically Inhibited by TriazolobenzodiazepinesScience, 1984
- VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF)Peptides, 1984
- CV-3988 - A specific antagonist of platelet activating factor (PAF)Life Sciences, 1983